Speaking of Leap years...February 21st, 2020...Leronlimab and Cancer.
Cytodyn announces Institutionalized Review Board Approval to initiate a Phase 2 Basket Trial for 22 Solid Tumor cancers...doesn't seem that long ago.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-